Atrial fibrillation Trials in Copenhagen, Denmark
Conditions / Atrial fibrillation / Copenhagen, Denmark
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04226547 | Amplatzer Amulet LAAO vs. NOAC | ACTIVE_NOT_RECRUITING | NA |
| NCT04590898 | Peri-device Leakage Closure After LAAO | COMPLETED | — |
| NCT02447081 | Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) | COMPLETED | — |
| NCT00403767 | An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT00781391 | Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation | COMPLETED | PHASE3 |
| NCT03642509 | Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation | RECRUITING | NA |
| NCT01830543 | A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT02036450 | Atrial Fibrillation Detected by Continuous ECG Monitoring | COMPLETED | NA |